The Burroughs Wellcome Fund (BWF) has selected Emory University for a $2.5 million, five-year award aimed at training new biomedical scientists whose expertise in research and teaching will bridge laboratory and population sciences.
The Emory program is one of three new BWF programs funded nationally within the Institutional Program Unifying Population and Laboratory Based Sciences. The other two programs will be located at the University of California, Los Angeles (metabolic diseases) and the University of Texas, Houston Health Science Center (gene-environment interaction).
The training awards, focused on understanding and improving human health, were created to connect population and computational sciences with laboratory-based biological sciences. The goal is to establish training programs that partner researchers in schools of medicine with those in schools of public health, as well as with a diverse range of other partners.
Emory's program, housed within the Emory University Graduate School, will create a new doctoral pathway called Human Health: Molecules to Mankind (M2M), with the theme of "Understanding human health: integrating biology, behaviors, environments and populations." Each doctoral student will train within two existing PhD programs, one in a laboratory science and one in a population science.
Kenneth Brigham, MD, director of the Emory/Georgia Tech Predictive Health Institute, will direct the M2M program with Michele Marcus, PhD, director of graduate studies and professor in the Department of Epidemiology at Emory's Rollins School of Public Health.
"The M2M program will create a bridge between these two areas of laboratory and population sciences, with the goal of creating a new kind of biomedical scientist," says Brigham. "With Emory's emphasis on cross-disciplinary education and research, and with a strategic plan that includes predictive health, global health, and computational and life sciences, our university is ideally positioned to become fully engaged in this pioneering program with our students and faculty."
Students will enroll in the Emory Graduate School and will align with existing PhD programs or with a new proposed PhD program in predictive health in Emory School of Medicine and the Rollins School of Public Health. Emory College will be a key participant, along with collaborators at the Centers for Disease Control and Prevention and the Georgia Institute of Technology. A collaboration with the Atlanta Clinical and Translational Science Institute also involves the Morehouse School of Medicine, Kaiser Permanente of Georgia and Children's Healthcare of Atlanta.
Lisa A. Tedesco, PhD, dean of the Graduate School, is excited about the project. "The M2M program brings together faculty and resources from many areas to train a new generation of scientists who can approach biomedical research with a new level of comprehensive and interconnected skill and expertise," she says. "It is an excellent example of reconfiguring graduate education to address difficult problems at a new level, and we are pleased to be a part of it."
Emory and partner institutions will provide an extensive background of related research projects, partnerships, and research and educational infrastructure that will enrich the new M2M training program. These include, among others, the Emory/Georgia Tech Predictive Health Institute, Emory Global Health Institute, the Hubert Department of Global Health and the Department of Epidemiology in the Rollins School of Public Health, the Emory Graduate Division of Biological and Biomedical Sciences, the joint Coulter Department of Biomedical Engineering at Georgia Tech and Emory, and the Emory-led Atlanta Clinical and Translational Science Institute (ACTSI).
The program initially will include four tracks, although others could be included as the program develops:
The M2M program also will offer an elective global science experience through the Emory Global Health Institute, the CDC and existing Emory collaborative programs in a variety of countries.
According to the Burroughs Wellcome Fund, trainees of its new programs may bring "new approaches to combining genomics with phenomics, addressing questions of population genetics, understanding molecular and environmental epidemiology, and a range of other issues important to understanding human health and its disruptors."
|Contact: Holly Korschun|